Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy
International Journal of Cancer · 2023
DOI: 10.1002/ijc.34457 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Daria Klusa und 22 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University …. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Prostatic Neoplasms, Bone Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutschen Konsortium für Translationale Krebsforschung.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Ablative radiotherapy is a highly efficient treatment modality for patients with metastatic prostate cancer (PCa). However, a subset of patients does not respond. Currently, this subgroup with bad prognosis cannot be identified before disease progression. We hypothesize that markers indicative of radioresistance, stemness and/or bone tropism may have a prognostic potential to identify patients profiting from metastases‐directed radiotherapy. Therefore, circulating tumor cells (CTCs) were analyzed in patients with metastatic PCa (n = 24) during radiotherapy with CellSearch, multicolor flow cytometry and imaging cytometry. Analysis of copy‐number alteration indicates a polyclonal CTC population that changes after radiotherapy. CTCs were found in 8 out of 24 patients (33.3%) and were associated with a shorter time to biochemical progression after radiotherapy. Whereas the total CTC count dropped after radiotherapy, a chemokine receptor CXCR4‐expressing subpopulation representing 28.6% of the total CTC population remained stable up to 3 months. At once, we observed higher chemokine CCL2 plasma concentrations and proinflammatory monocytes. Additional functional analyses demonstrated key roles of CXCR4 and CCL2 for cellular radiosensitivity, tumorigenicity and stem‐like potential in vitro and in vivo. Moreover, a high CXCR4 and CCL2 expression was found in bone metastasis biopsies of PCa patients. In summary, panCK + CXCR4 + CTCs may have a prognostic potential in patients with metastatic PCa treated with metastasis‐directed radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, and Helmho…
- OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
- German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Radiation Oncology, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Department of Obstetrics and Gynecology, Medical Faculty and University Hospital of the Heinrich-Heine University, Düsseldorf, Germany.
- Department of Biology, Maynooth University, Maynooth, Ireland.
ORCID-Profile: Bernhard Polzer, Sven Perner, Anna Dubrovska, Claudia Peitzsch
Förderung
- Deutsche Forschungsgemeinschaft
- Deutschen Konsortium für Translationale Krebsforschung
Zitieren
APA
Klusa, D., Lohaus, F., Franken, A., Baumbach, M., Cojoc, M., Dowling, P., Linge, A., Offermann, A., Löck, S., Hušman, D., Rivandi, M., Polzer, B., Freytag, V., Lange, T., Neubauer, H., Kücken, M., Perner, S., Hölscher, T., Dubrovska, A., …, & Peitzsch, C. (2023). Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy. International Journal of Cancer. https://doi.org/10.1002/ijc.34457
Vancouver
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, et al. Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy. International Journal of Cancer. 2023. doi:10.1002/ijc.34457
BibTeX
@article{Klusa2023,
author = {Klusa, Daria and Lohaus, Fabian and Franken, Andre and Baumbach, Marian and Cojoc, Monica and Dowling, Paul and Linge, Annett and Offermann, Anne and Löck, Steffen and Hušman, Dejan and Rivandi, Mahdi and Polzer, Bernhard and Freytag, Vera and Lange, Tobias and Neubauer, Hans and Kücken, Michael and Perner, Sven and Hölscher, Tobias and Dubrovska, Anna and Krause, Mechthild and Kurth, Ina and Baumann, Michael and Peitzsch, Claudia},
title = {Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy},
journal = {International Journal of Cancer},
year = {2023},
doi = {10.1002/ijc.34457}
}
EUVIMED